Enjoy complimentary customisation on priority with our Enterprise License!
The new drug delivery systems market size is forecast to increase by USD 55.1 billion at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of chronic diseases among pediatric and geriatric patients. Minimally invasive surgeries and home-care settings are driving the demand for advanced drug delivery systems. However, patent expiry and regulatory hurdles pose challenges to market growth. In the biopharmaceutical market, there is a growing focus on developing drugs for conditions such as kidney diseases, where traditional drug delivery methods have limitations. Furthermore, the development of technologies for delivering poorly soluble drugs is a major trend in the market. Despite these opportunities, the market faces challenges from stringent regulations and the need for extensive clinical trials to ensure safety and efficacy.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.